中国全科医学 ›› 2020, Vol. 23 ›› Issue (35): 4430-4435.DOI: 10.12114/j.issn.1007-9572.2020.00.588

所属专题: 新型冠状病毒肺炎最新文章合集

• 专题研究 • 上一篇    下一篇

PCR-核酸飞行时间质谱系统检测新型冠状病毒方法的建立及应用研究

王俊1,张栋2,陈晴晴1,俞俊岭1,杨奕3,乔亮3,孙永1*   

  1. 1.230601安徽省合肥市,安徽省疾病预防控制中心 2.100730北京市,中国医学科学院 北京协和医院检验科 3.200433上海市,复旦大学化学系
    *通信作者:孙永,副主任技师;E-mail:biosunyong@163.com
  • 出版日期:2020-12-15 发布日期:2020-12-15
  • 基金资助:
    安徽省新型冠状病毒肺炎疫情应急科研攻关(202004a07020004)

Establishment and Application of PCR-Time-of-flight Mass Spectrometer for SARS-CoV-2 Nucleic Acid Detection 

WANG Jun1,ZHANG Dong2,CHEN Qingqing1,YU Junling1,YANG Yi3,QIAO Liang3,SUN Yong1*   

  1. 1.Anhui Provincial Center for Disease Control and Prevention,Hefei 230601,China
    2.Clinical Laboratory,Chinese Academy of Medical Sciences & Peking Union Medical College Hospital,Beijing 100730,China
    3.Department of Chemistry,Fudan University,Shanghai 200433,China
    *Corresponding author:SUN Yong,Associate chief technician;E-mail:biosunyong@163.com
  • Published:2020-12-15 Online:2020-12-15

摘要: 背景 新型冠状病毒肺炎(COVID-19)在全球暴发,实验室检测结果是疾病诊断的重要依据,检测方法的灵敏度和特异度是影响实验结果的关键因素,现实时荧光定量聚合酶链反应(PCR)核酸检测方法是COVID-19确诊的通用方法,但其检测灵敏度有方法局限性,依赖标本病毒含量。通过对PCR-核酸飞行时间质谱检测方法的优化,从而提高对低新型冠状病毒(SARS-CoV-2)含量病例检测的灵敏度,可为现有方法做有效补充。目的 应用基质辅助激光解吸电离飞行时间质谱(MALDI-TOF MS)原理,在Clin-ToF Ⅱ飞行时间质谱系统上,建立PCR-核酸飞行时间质谱(PCR-TOF MS)系统检测SARS-CoV-2的方法,并评估其实际应用价值。方法 2020年2—3月于上海市临床检验中心室间质评阳性样本40份、阴性样本7份,国家卫生健康委员会室间质评阳性样本41份、阴性样本33份,本实验室购买阳性质粒及稀释样本32份,健康人样本28份,空白对照超纯水5份,共186份样本作为建立PCR-TOF MS系统数据。于2020年1—2月收集安徽省内临床送检到安徽省疾病预防控制中心的疑似COVID-19患者上呼吸道样本80份(咽拭子样本55份、痰液样本25份)及健康人群样本20份(均为咽拭子样本)作为评估PCR-TOF MS系统效果的数据。建立PCR-TOF MS系统试验体系步骤,包括PCR扩增、虾碱性磷酸酶(SAP)消化、单碱基延伸和质谱检测;并基于阳性质粒优化模版量,根据186份样本检测质谱峰的信噪比(SNP)确定该方法在SARS-CoV-2检测时的判读标准。对80份疑似SARS-CoV-2样本和20份健康人群样本进行检测分析,并与实时荧光定量PCR法进行对比。结果 通过对PCR-TOF MS 模板条件的优化,模版量6 μl时,扩增产物可获得典型的质谱峰图。建立的PCR-TOF MS反应体系可以对SARS-CoV-2核酸的开放读码框1ab(ORF1ab)基因和核壳蛋白(N)基因进行有效扩增检测。本研究PCR-TOF MS方法对临床疑似病例样本的检出率为90.00%,高于实时荧光定量PCR法的75.00%,同时,结果显示,实时荧光定量PCR法检出中含有25.00%的可疑结果,而PCR-TOF MS则无可疑结果。对于痰液和咽拭子两种样本的检出率,PCR-TOF MS法分别为100.00%和85.45%,高于荧光定量PCR法的64.00%和43.64%。阴性样本两种方法均未检出。结论 通过PCR技术与飞行时间质谱技术的结合,使得检测SARS-CoV-2目标片段指数级扩大,从而提高样本的检测灵敏度。MALDI-TOF MS技术通过对离子分子量的检测分析,具有较高的准确性和特异性,同时证实了痰液样本优于咽拭子样本。该方法可作为实时荧光定量PCR法的补充和协同,在一定程度上有利于弥补假阴性的问题,从而降低临床漏诊率,提高检测效率,为疫情的研判缩短时间。

关键词: 新型冠状病毒肺炎, 新型冠状病毒, PCR-飞行质谱系统, 基质辅助激光解吸电离飞行时间质谱, 核酸检测

Abstract: Background To contain the COVID-19 pandemic,laboratory test results are an important reference for making diagnosis whose accuracy is closely associated with the sensitivity and specificity of the detection method.RT-PCR is a general detection method for SARS-CoV-2,but its sensitivity is limited and depends on the content of virus.Optimizing PCR-Time-of-flight mass spectrometry (TOFMS) may improve the sensitivity of low virus content detection,which may be an effective supplement to the existing methods.Objective To develop a PCR-TOFMS method for detecting SARS-CoV-2 nucleic acid based on Clin-ToF-II TOFMS system using matrix-assisted laser desorption/ionization(MALDI)principle,and evaluate its practical application value.Methods 186 samples were used as the data for developing a system of PCR-TOFMS,including 121 external quality assessment samples〔47(40 were SARS-CoV-2 positive and 7 were negative)from Shanghai Center for Clinical Laboratory,and 74(41 were SARS-CoV-2 positive and 33 were negative)from National Health Commission of the People's Republic of China〕,and 65(32 positive plasmids and diluted samples,28 samples of healthy people and 5 of ultrapure water as blank control) bought by our laboratory.Another 100 samples collected during January to February,2020,were used as the data for testing the performance of our system of PCR-TOFMS, including 80 samples of upper respiratory tract secretions(55 throat swab samples, and 25 sputum samples) of suspected COVID-19 cases collected clinically by Anhui's hospitals and sent to Anhui Provincial Center for Disease Control and Prevention for detection,and 20 throat swab samples of healthy people.The detection procedure for the system was developed, including PCR amplification, SAP digestion, single-base extension and mass spectrometry detection. Based on the positive plasmid,the template quantity was optimized.The diagnostic criterion for SARS-CoV-2 was determined according to the peak signal-to-noise ratio of 186 samples' results. The samples of 80 suspected COVID-19 cases and 20 healthy people were analyzed,and the results were compared with those by RT-PCR.Results By optimizing the template conditions of PCR-TOF MS,the typical mass spectra of PCR-TOFMS was obtained when the template amount was 6 μl.The established RT-PCR reaction system could effectively detect the amplification of ORF1ab gene and nucleocapsid protein (N) gene of SARS-CoV-2 nucleic acid. In this study,the detection rate of PCR-TOFMS for clinically suspected cases was 90.00%,which was higher than 75.00% of RT-PCR. Meanwhile,the results showed that 25.00% of suspicious results were detected by RT-PCR,but no suspicious results were found by PCR-TOFMS. PCR-TOFMS had higher rates of detecting SARS-CoV-2 in sputum samples(100.00% vs 64.00%)and throat swab samples(85.45% vs 43.64%)of suspected COVID-19 cases than RT-PCR,but both of them did not find SARS-CoV-2 in negative samples.Conclusion The combination of PCR and TOFMS technology makes the detection of SARS-CoV-2 target fragment expand exponentially,thereby improving the detection sensitivity of samples.In addition,MALDI-TOF MS technology has high accuracy and specificity through the detection and analysis of ion molecular weight,which also confirms that sputum sample is better than throat swab sample for detection.This method can be used as a supplement and collaboration of RT-PCR,which can make up for the false negative problem to a certain extent,thus reducing the clinical missed diagnosis rate,improving the detection efficiency,and shortening the time for pandemic situation research and judgment.

Key words: COVID-19, SARS-CoV-2, PCR-TOF MS, MALDI-TOF MS, Nucleic acid testing